The lab analyst performs a genomic sequence analysis panel to evaluate the patient tumor specimen for DNA sequence variants and copy number variants known to impact diagnosis and treatment of solid organ cancers. The test also evaluates microsatellite instability (MSI), which is an indicator of how likely the cells are to mutate and may guide treatment options.
For clinical responsibility, terminology, tips and additional info
start codify free trial.